SCHEMBL5408340

SCHEMBL5408340

Cc1ccc(CCN(CCC(=O)O)C(=O)c2ccccc2-c2ccccc2C(=O)NCc2cccc(F)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
FFAR1 O14842 1/20 0.44
RAB9A P51151 1/20 0.44
POLB P06746 3/20 0.42
TP53 P04637 1/20 0.42
PPARG P37231 2/20 0.42
SRC P12931 1/20 0.42
KDM4E B2RXH2 2/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 1/20 0.41
LPAR1 Q92633 1/20 0.41
HDAC1 Q13547 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
AKR1C4 P17516 1/20 0.40
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA4 P43681 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5402851 0.94 FFAR1 (0.47) FFAR1RAB9APOLBTP53PPARG
SCHEMBL5402559 0.93 ALDH1A1 (0.46) ALDH1A1RAB9ATP53PPARGKDM4E
SCHEMBL5413978 0.92 ALDH1A1 (0.50) ALDH1A1FFAR1RAB9APPARGKDM4E
SCHEMBL5399508 0.91 ALDH1A1 (0.50) ALDH1A1TP53KDM4EHPGDHSD17B10
SCHEMBL5399793 0.91 ALDH1A1 (0.57) ALDH1A1FFAR1RAB9ATP53PPARG
SCHEMBL5418399 0.91 ALDH1A1 (0.57) ALDH1A1FFAR1RAB9ATP53PPARG
SCHEMBL5412186 0.90 RAB9A (0.53) ALDH1A1FFAR1RAB9ATP53KDM4E
SCHEMBL5409246 0.90 LPAR1 (0.48) FFAR1RAB9APOLBTP53PPARG
SCHEMBL5402458 0.90 ALDH1A1 (0.55) ALDH1A1FFAR1TP53PPARGKDM4E
SCHEMBL5399021 0.89 MEN1 (0.47) ALDH1A1RAB9APOLBPPARGKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285680-B2 β-alanine derivatives and the use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-10-23 US disclosed
US-20050256160-A1 Beta-alanine derivatives and the use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2005-11-17 US disclosed
EP-1533294-A1 BETA-ALANINE DERIVATIVE AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-05-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256160-A1 Beta-alanine derivatives and the use thereof TGFB1, PML, APOB ALDH1A1 1256/4885FFAR1 65/4885RAB9A 3132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.